Creso Pharma Limited Valuation
| COPHFDelisted Stock | USD 0.12 0.00 0.00% |
Creso Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Creso Pharma Limited from analyzing the firm fundamentals such as profit margin of (2.41) %, and Return On Equity of -0.67 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Creso Pharma's price fluctuation is very steady at this time. Calculation of the real value of Creso Pharma Limited is based on 3 months time horizon. Increasing Creso Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Creso pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Creso Pharma Limited. Since Creso Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Creso Pink Sheet. However, Creso Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.12 | Real 0.1 | Hype 0.12 |
The real value of Creso Pink Sheet, also known as its intrinsic value, is the underlying worth of Creso Pharma Limited Company, which is reflected in its stock price. It is based on Creso Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Creso Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Creso Pharma Limited helps investors to forecast how Creso pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Creso Pharma more accurately as focusing exclusively on Creso Pharma's fundamentals will not take into account other important factors: Creso Pharma Total Value Analysis
Creso Pharma Limited is currently forecasted to have takeover price of 24.06 M with market capitalization of 49.92 M, debt of 3.26 M, and cash on hands of 3.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Creso Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.06 M | 49.92 M | 3.26 M | 3.14 M |
Creso Pharma Investor Information
About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creso Pharma Limited recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Creso Pharma's financial statements, Creso Pharma Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Creso Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Creso Pharma has an asset utilization ratio of 21.21 percent. This implies that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that Creso Pharma Limited is more efficient with each dollar of assets it utilizes for everyday operations.Creso Pharma Ownership Allocation
Creso Pharma holds a total of 2 Billion outstanding shares. Creso Pharma Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Creso Pharma Profitability Analysis
The company reported the revenue of 6.22 M. Net Loss for the year was (30.03 M) with loss before overhead, payroll, taxes, and interest of (400.39 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Creso Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Creso Pharma and how it compares across the competition.
About Creso Pharma Valuation
The pink sheet valuation mechanism determines Creso Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Creso Pharma. We calculate exposure to Creso Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Creso Pharma's related companies.Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Creso Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Creso Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Creso Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Creso Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Creso Pharma's revenue streams: Identify Creso Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Creso Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Creso Pharma's growth potential: Evaluate Creso Pharma's management, business model, and growth potential.
- Determine Creso Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Creso Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Creso Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Creso Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 B | |
| Retained Earnings | -94.8 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |